These findings led to a suggested role for GIP in the development of obesity, highlighting the therapeutic opportunity of GIP receptor antagonism, and subsequently leading to great interest and research activity within the field (53). This evidence concerns the gene GIP and obesity due to melanocortin 4 receptor deficiency.